Raymond J Bergeron1, Neelam Bharti2, James S McManis2, Jan Wiegand2. 1. JHMHC, Department of Medicinal Chemistry, University of Florida, Box 100485, Gainesville, FL 32610-0485, United States. Electronic address: rayb@ufl.edu. 2. JHMHC, Department of Medicinal Chemistry, University of Florida, Box 100485, Gainesville, FL 32610-0485, United States.
Abstract
Extensive structure activity relationship (SAR) studies focused on the desferrithiocin [DFT, (S)-4,5-dihydro-2-(3-hydroxy-2-pyridinyl)-4-methyl-4-thiazolecarboxylic acid] pharmacophore have led to three different DFT analogs being evaluated clinically for the treatment of iron overload diseases, for example, thalassemia. The SAR work revealed that the lipophilicity of a ligand, as determined by its partition between octanol and water, logP(app), could have a profound effect on the drug's iron clearing efficiency (ICE), organ distribution, and toxicity profile. While within a given structural family the more lipophilic a chelator the better the ICE, unfortunately, the more lipophilic ligands are often more toxic. Thus, a balance between lipophilicity, ICE, and toxicity must be achieved. In the current study, we introduce the concept of 'metabolically programmed' iron chelators, that is, highly lipophilic, orally absorbable, effective deferration agents which, once absorbed, are quickly converted to their nontoxic, hydrophilic counterparts.
Extensive structure activity relationship (SAR) studies focused on the desferrithiocin [n class="Chemical">DFT, (S)-4,5-dihydro-2-(3-hydroxy-2-pyridinyl)-4-methyl-4-thiazolecarboxylic acid] pharmacophore have led to three different DFT analogs being evaluated clinically for the treatment of iron overload diseases, for example, thalassemia. The SAR work revealed that the lipophilicity of a ligand, as determined by its partition between octanol and water, logP(app), could have a profound effect on the drug's iron clearing efficiency (ICE), organ distribution, and toxicity profile. While within a given structural family the more lipophilic a chelator the better the ICE, unfortunately, the more lipophilic ligands are often more toxic. Thus, a balance between lipophilicity, ICE, and toxicity must be achieved. In the current study, we introduce the concept of 'metabolically programmed' iron chelators, that is, highly lipophilic, orally absorbable, effective deferration agents which, once absorbed, are quickly converted to their nontoxic, hydrophilic counterparts.
Authors: John P Wojcik; Mark R Speechley; Ann E Kertesz; Subrata Chakrabarti; Paul C Adams Journal: Can J Gastroenterol Date: 2002-05 Impact factor: 3.522
Authors: Hanspeter Nick; Agnes Wong; Pierre Acklin; Bernard Faller; Yi Jin; René Lattmann; Thomas Sergejew; Suzanne Hauffe; Helmut Thomas; Hans Peter Schnebli Journal: Adv Exp Med Biol Date: 2002 Impact factor: 2.622
Authors: R J Bergeron; R R Streiff; J Wiegand; J R Vinson; G Luchetta; K M Evans; H Peter; H B Jenny Journal: Ann N Y Acad Sci Date: 1990 Impact factor: 5.691
Authors: Yuzhao Zhou; Vishal S Vaidya; Ronald P Brown; Jun Zhang; Barry A Rosenzweig; Karol L Thompson; Terry J Miller; Joseph V Bonventre; Peter L Goering Journal: Toxicol Sci Date: 2007-10-13 Impact factor: 4.849